BRANCACCIO, Mara
 Distribuzione geografica
Continente #
NA - Nord America 4318
EU - Europa 3099
AS - Asia 1024
AF - Africa 22
OC - Oceania 16
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8487
Nazione #
US - Stati Uniti d'America 4255
DK - Danimarca 790
CN - Cina 719
IT - Italia 638
DE - Germania 291
IE - Irlanda 273
SE - Svezia 228
UA - Ucraina 173
FR - Francia 168
AT - Austria 126
FI - Finlandia 106
GB - Regno Unito 89
VN - Vietnam 88
PL - Polonia 78
KR - Corea 73
CA - Canada 56
JP - Giappone 39
PT - Portogallo 34
IN - India 31
TW - Taiwan 26
BE - Belgio 25
NL - Olanda 17
SN - Senegal 17
AU - Australia 15
HK - Hong Kong 13
RU - Federazione Russa 12
ES - Italia 11
HR - Croazia 8
IR - Iran 8
CZ - Repubblica Ceca 7
RO - Romania 7
CH - Svizzera 5
GR - Grecia 5
IL - Israele 5
BR - Brasile 4
PR - Porto Rico 4
TR - Turchia 4
EG - Egitto 3
MX - Messico 3
MY - Malesia 3
RS - Serbia 3
SG - Singapore 3
BY - Bielorussia 2
CL - Cile 2
HU - Ungheria 2
MO - Macao, regione amministrativa speciale della Cina 2
PK - Pakistan 2
SA - Arabia Saudita 2
AR - Argentina 1
BT - Bhutan 1
EU - Europa 1
JO - Giordania 1
LU - Lussemburgo 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 8487
Città #
Ann Arbor 1017
Chandler 570
Beijing 368
Fairfield 337
Dublin 273
Houston 252
Torino 239
Wilmington 227
Ashburn 189
Woodbridge 158
Jacksonville 155
Seattle 129
Vienna 123
Dearborn 118
Cambridge 102
Villeurbanne 91
Nyköping 79
Pisa 78
Princeton 77
Medford 71
Warsaw 67
Redwood City 63
Dong Ket 60
Fremont 54
Turin 43
Munich 40
Nanjing 33
Shanghai 33
Boston 32
Milan 27
Hangzhou 26
San Diego 22
Taipei 22
Brussels 19
Guangzhou 19
Montréal 18
Grafing 16
Palaiseau 16
Boardman 15
Chengdu 15
Duncan 15
Hefei 15
Kunming 14
Rome 13
Silver Spring 13
Toronto 13
Xian 13
Zhengzhou 13
Hebei 12
Buffalo 11
Paris 11
Phoenix 11
Verona 11
Düsseldorf 10
Wuhan 10
Jinan 9
La Jolla 9
Ottawa 9
Guiyang 8
Nanchang 8
San Mateo 8
Tokyo 8
Falls Church 7
Padova 7
Seoul 7
Zagreb 7
Changsha 6
Edmonton 6
Fuzhou 6
Norwalk 6
Piemonte 6
Redmond 6
Siena 6
Berlin 5
Chennai 5
Heidelberg 5
Lachine 5
Lund 5
Polska 5
Shenzhen 5
Central District 4
Mountain View 4
Scarmagno 4
Baotou 3
Birmingham 3
Bologna 3
Capaccio 3
Columbus 3
Dallas 3
Gallicano 3
Hanover 3
Harbin 3
Kish 3
Leawood 3
London 3
Los Angeles 3
Napoli 3
Newcastle 3
Philadelphia 3
Redes 3
Totale 5705
Nome #
Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarction. 402
Morgana acts as an oncosuppressor in chronic myeloid leukemia. 396
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones 300
The muscle-specific chaperone protein melusin is a potent cardioprotective agent 244
Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma 231
Integrin function and regulation in development. 230
Tissue-specific KO of ECM proteins. 223
Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. 218
Melusin is a new muscle-specific interactor for beta(1) integrin cytoplasmic domain. 216
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts 216
Morgana is a new oncosuppressor in CML 215
Gli animali transgenici: frontiera tra la ricerca fondamentale e applicata. 213
Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure 213
Defective Rac-mediated proliferation and survival after targeted mutation of the beta(1) integrin cytodomain 211
Tissue-specific KO of ECM proteins 210
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 209
Morgana/chp-1, a ROCK inhibitor involved in centrosome duplication and tumorigenesis 204
Overexpression of the muscle-specific protein, melusin, protects from cardiac ischemia/reperfusion injury. 190
Tissue-specific KO of ECM proteins 187
IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload. 186
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 186
PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects 183
Integrin signalling: The tug-of-war in heart hypertrophy 175
Biomimetic engineering of the cardiac tissue through processing, functionalization, and biological characterization of polyester urethanes 155
The double face of Morgana in tumorigenesis 144
ERK1/2 activation in heart is controlled by melusin, focal adhesion kinase and the scaffold protein IQGAP1. 139
Surface functionalization of polyurethane scaffolds mimicking the myocardial microenvironment to support cardiac primitive cells 118
Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia 117
Melusin Promotes a Protective Signal Transduction Cascade in Stressed Hearts. 113
The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis 103
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS 102
ALTERNATIVE SPLICING VARIANT COULD BE RESPONSIBLE OF MORGANA UNDER-EXPRESSION IN ACML 92
The one thousand and one chaperones of the NF-κB pathway 89
Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia 87
Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia 81
The mammalian CHORD-containing protein melusin is a stress response protein interacting with Hsp90 and Sgt1 80
ROCK AS THERAPEUTICAL TARGET FOR MORGANA LOW CML 80
MBP-mediated molecular cargo delivery into cells 79
MELUSIN, A MUSCLE SPECIFIC PROTEIN, AS A DRUG TARGET FOR PREVENTION AND TREATMENT OF HEART FAILURE AND APPLICATIONS THEREOF 78
Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload 78
Tumor suppressors in chronic lymphocytic leukemia: From lost partners to active targets 77
Morgana acts as a proto-oncogene through inhibition of a ROCK-PTEN pathway. 75
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches 73
MORGANA/CHP1 ACTS AS AN ONCOSUPPRESSOR IN CHRONIC MYELOID LEUKEMIA 73
Altered melusin expression in the hearts of aortic stenosis patients 72
Redox aspects of chaperones in cardiac function 70
Escaping NK cells and recruiting neutrophils: How Morgana/NF-κB signaling promotes metastasis 70
Chp-1 and melusin, two CHORD containing proteins in vertebrates. 69
Differential onset of expression of alpha 7 and beta 1D integrins during mouse heart and skeletal muscle development 68
Cardiac Overexpression of Melusine Protects from Lipopolysaccharide-Induced Sepsis Cardiomyopathy 67
The dark-side of the outside: how extracellular heat shock proteins promote cancer 67
IκBα targeting promotes oxidative stress-dependent cell death 64
Therapeutic inhibition of HAUSP-PTEN network in chronic lymphocytic leukemia 60
Master Regulators of Muscle Atrophy: Role of Costamere Components 60
Targeting the extracellular HSP90 co-chaperone Morgana inhibits cancer cell migration and promotes anti-cancer immunity 58
Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies and compositions thereof 55
Blocking Extracellular Chaperones to Improve Cardiac Regeneration 55
Morgana haploinsufficiency induces a myeloproliferative disorder like-chronic myeloid leukemia in mice. 54
The integrin cytoplasmic domain-associated protein ICAP-1 binds and regulates Rho family GTPases during cell spreading 51
Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK 51
Morgana/CHP-1 is a novel chaperone able to protect cells from stress 51
Drosophila Morgana is an Hsp90-interacting protein with a direct role in microtubule polymerisation 50
Morgana and Melusin: Two fairies chaperoning signal transduction. 47
Distribution and localization of vinculin-talin-integrin system and dystrophin-glycoprotein complex in human skeletal muscle. Immunohistochemical study using confocal laser scanning microscopy. 46
Phosphoinositide 3-kinase (P110alpha) directly regulates key components of the Z-disc and cardiac structure. 45
Loss of melusin is a novel, neuronal NO synthase/FoxO3-independent master switch of unloading-induced muscle atrophy 44
Activated ROCK II by-passes the requirement of the CDK2 activity for centrosome duplication and amplification. 38
Mechanisms underlying the cross-talk between heart and cancer 33
Key role of ERK1/2 molecular scaffolds in heart pathology. 28
Modulation of LTCC Pathways by A Melusin Mimetic Increases Ventricular Contractility During LPS-Induced Cardiomyopathy 27
Keep your heart in shape: molecular chaperone networks for treating heart disease. 24
Melusin gene (ITGB1BP2) nucleotide variations study in hypertensive and cardiopathic patients 23
Extracellular HSP90 Machineries Build Tumor Microenvironment and Boost Cancer Progression 23
A TRICk to Improve the Effectiveness of RIC: Role of Limb Temperature in Enhancing the Effectiveness of Remote Ischemic Conditioning 22
Understanding Aberrant Signaling to Elude Therapy Escape Mechanisms in Myeloproliferative Neoplasms 20
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy 15
The NFKBIA’s amplification in cancer, emerging molecular targets for lung cancer therapy 6
Shedding Light on NF-κB Functions in Cellular Organelles 3
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy 2
Totale 8829
Categoria #
all - tutte 13053
article - articoli 0
book - libri 0
conference - conferenze 1278
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018578 0000 00 0158 2471263215
2018/2019626 30112223 2132 28106 387217073
2019/20202139 6070125127 176274 240211 224237204191
2020/20211410 95859443 91119 15062 164143111253
2021/20221880 161170137245 105154 151130 10083254190
2022/20231192 16015734150 164397 1300 0000
Totale 8829